Quarterly Result27 Apr 2026, 08:43 pm
Astec Lifesciences Approves Q4/FY26 Results; 32nd AGM on July 31, 2026
AI Summary
Astec Lifesciences' Board of Directors approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, with an unmodified opinion from statutory auditors. The 32nd Annual General Meeting (AGM) is scheduled for Friday, July 31, 2026, with book closure from July 26 to July 30, 2026. The Board also proposed seeking shareholder approval via postal ballot for the appointment of Mr. Vishal Sharma, Mr. Burjis N. Godrej, Mr. Arijit Mukherjee, and Mr. Mathew Eipe as directors, and for entering into material related party transactions during FY2026-27.
Key Highlights
- Board approved audited Q4 and FY26 standalone and consolidated financial results.
- Statutory auditors issued an unmodified opinion on the financial results.
- 32nd Annual General Meeting (AGM) to be held on July 31, 2026.
- Book closure dates for the AGM are July 26-30, 2026.
- Shareholder approval sought via postal ballot for director appointments and RPTs.
Price Impact
More from ASTEC